Health Systems and Reform Journal
@hsrjournal.bsky.social
First journal dedicated to research, theory, and analysis in #healthsystems and #healthreform🌍 ┃Publisher: @tandfresearch.bsky.social
https://www.tandfonline.com/toc/khsr20/current
https://www.tandfonline.com/toc/khsr20/current
➡️Rejecting Inclusion Requests Based on HTA Evidence
The inclusion of ribociclib and palbociclib in the health benefits package was denied because the cost-effectiveness analysis revealed their inclusion remains cost-ineffective in India even with a 95% price reduction.
Read more: bit.ly/3wtaT6Y
The inclusion of ribociclib and palbociclib in the health benefits package was denied because the cost-effectiveness analysis revealed their inclusion remains cost-ineffective in India even with a 95% price reduction.
Read more: bit.ly/3wtaT6Y
November 13, 2025 at 8:55 AM
➡️Rejecting Inclusion Requests Based on HTA Evidence
The inclusion of ribociclib and palbociclib in the health benefits package was denied because the cost-effectiveness analysis revealed their inclusion remains cost-ineffective in India even with a 95% price reduction.
Read more: bit.ly/3wtaT6Y
The inclusion of ribociclib and palbociclib in the health benefits package was denied because the cost-effectiveness analysis revealed their inclusion remains cost-ineffective in India even with a 95% price reduction.
Read more: bit.ly/3wtaT6Y
➡️Using HTA evidence for revising standard treatment guidelines
HeFTA evaluated HTA evidence on trastuzumab cycles for breast cancer, finding it cost-effective to raise the PM-JAY cycle cap from four to eight. Accordingly, the STGs were revised👇
HeFTA evaluated HTA evidence on trastuzumab cycles for breast cancer, finding it cost-effective to raise the PM-JAY cycle cap from four to eight. Accordingly, the STGs were revised👇
November 13, 2025 at 8:55 AM
➡️Using HTA evidence for revising standard treatment guidelines
HeFTA evaluated HTA evidence on trastuzumab cycles for breast cancer, finding it cost-effective to raise the PM-JAY cycle cap from four to eight. Accordingly, the STGs were revised👇
HeFTA evaluated HTA evidence on trastuzumab cycles for breast cancer, finding it cost-effective to raise the PM-JAY cycle cap from four to eight. Accordingly, the STGs were revised👇
As a result, a PD-focused policy for newly diagnosed end-stage renal disease PM- JAY beneficiaries was adopted. It will lead to
➖Higher QALYs (3.3 QALYs per person compared with 1.6 QALYs of dose treated with HD)
➖Lifetime cost savings of 1,213 USD to 8,491 USD per person
👇
➖Higher QALYs (3.3 QALYs per person compared with 1.6 QALYs of dose treated with HD)
➖Lifetime cost savings of 1,213 USD to 8,491 USD per person
👇
November 13, 2025 at 8:55 AM
As a result, a PD-focused policy for newly diagnosed end-stage renal disease PM- JAY beneficiaries was adopted. It will lead to
➖Higher QALYs (3.3 QALYs per person compared with 1.6 QALYs of dose treated with HD)
➖Lifetime cost savings of 1,213 USD to 8,491 USD per person
👇
➖Higher QALYs (3.3 QALYs per person compared with 1.6 QALYs of dose treated with HD)
➖Lifetime cost savings of 1,213 USD to 8,491 USD per person
👇
➡️Using HTA evidence for policy formulation
The Health Financing and Technology Assessment unit identified economic evidence indicating that peritoneal dialysis (PD) is a cost-saving therapy compared to hemodialysis (HD) in various countries and in India👇
The Health Financing and Technology Assessment unit identified economic evidence indicating that peritoneal dialysis (PD) is a cost-saving therapy compared to hemodialysis (HD) in various countries and in India👇
November 13, 2025 at 8:55 AM
➡️Using HTA evidence for policy formulation
The Health Financing and Technology Assessment unit identified economic evidence indicating that peritoneal dialysis (PD) is a cost-saving therapy compared to hemodialysis (HD) in various countries and in India👇
The Health Financing and Technology Assessment unit identified economic evidence indicating that peritoneal dialysis (PD) is a cost-saving therapy compared to hemodialysis (HD) in various countries and in India👇
3️⃣Involvement and support of international actors such as the International Decision Support Initiative and the National Institute for Health and Care Excellence.
Read more: bit.ly/4dKcdCT
Read more: bit.ly/4dKcdCT
November 10, 2025 at 8:30 AM
3️⃣Involvement and support of international actors such as the International Decision Support Initiative and the National Institute for Health and Care Excellence.
Read more: bit.ly/4dKcdCT
Read more: bit.ly/4dKcdCT
The “HTA ecosystem” within India developed with multiple organizations influencing and developing the formation and growth of the MTAB and HTAIn👇
November 10, 2025 at 8:30 AM
The “HTA ecosystem” within India developed with multiple organizations influencing and developing the formation and growth of the MTAB and HTAIn👇
The creation of India's HTA agency was facilitated by:
1️⃣Multiple champions creating multiple windows of opportunity
2️⃣Building a national governmental ecosystem👇
1️⃣Multiple champions creating multiple windows of opportunity
2️⃣Building a national governmental ecosystem👇
November 10, 2025 at 8:30 AM
The creation of India's HTA agency was facilitated by:
1️⃣Multiple champions creating multiple windows of opportunity
2️⃣Building a national governmental ecosystem👇
1️⃣Multiple champions creating multiple windows of opportunity
2️⃣Building a national governmental ecosystem👇
Implementing HTA policy
In 2019, the Ministry of Health established the HTA Technical Working Group and the Steering Committee as governance structures to oversee evidence and recommendations, and to advise the health minister, respectively
Read more: bit.ly/3QPZvJg
In 2019, the Ministry of Health established the HTA Technical Working Group and the Steering Committee as governance structures to oversee evidence and recommendations, and to advise the health minister, respectively
Read more: bit.ly/3QPZvJg
November 8, 2025 at 5:52 PM
Implementing HTA policy
In 2019, the Ministry of Health established the HTA Technical Working Group and the Steering Committee as governance structures to oversee evidence and recommendations, and to advise the health minister, respectively
Read more: bit.ly/3QPZvJg
In 2019, the Ministry of Health established the HTA Technical Working Group and the Steering Committee as governance structures to oversee evidence and recommendations, and to advise the health minister, respectively
Read more: bit.ly/3QPZvJg
➡️The Ghana Strategy for HTA was developed and launched by MOH in 2020
➡️The process guidelines for HTA defined the sequential and stepwise approach for HTA in this country
➡️The process guidelines for HTA defined the sequential and stepwise approach for HTA in this country
November 8, 2025 at 5:52 PM
➡️The Ghana Strategy for HTA was developed and launched by MOH in 2020
➡️The process guidelines for HTA defined the sequential and stepwise approach for HTA in this country
➡️The process guidelines for HTA defined the sequential and stepwise approach for HTA in this country
Adopting HTA policy
➡️A readiness assessment (2014-2015) provided foundational guidance for HTA institutionalization
➡️In 2018, HTA was included in the health sector "aide memoire", which summarized the decisions made at the national health summit👇
➡️A readiness assessment (2014-2015) provided foundational guidance for HTA institutionalization
➡️In 2018, HTA was included in the health sector "aide memoire", which summarized the decisions made at the national health summit👇
November 8, 2025 at 5:52 PM
Adopting HTA policy
➡️A readiness assessment (2014-2015) provided foundational guidance for HTA institutionalization
➡️In 2018, HTA was included in the health sector "aide memoire", which summarized the decisions made at the national health summit👇
➡️A readiness assessment (2014-2015) provided foundational guidance for HTA institutionalization
➡️In 2018, HTA was included in the health sector "aide memoire", which summarized the decisions made at the national health summit👇
Agenda-setting
➡️Ghana's Ministry of Health (MOH) and international organizations advocated for HTA
➡️Training activities and discussions led by MOH and supported by WHO increased awareness of HTA’s benefits
➡️Ghana's Ministry of Health (MOH) and international organizations advocated for HTA
➡️Training activities and discussions led by MOH and supported by WHO increased awareness of HTA’s benefits
November 8, 2025 at 5:52 PM
Agenda-setting
➡️Ghana's Ministry of Health (MOH) and international organizations advocated for HTA
➡️Training activities and discussions led by MOH and supported by WHO increased awareness of HTA’s benefits
➡️Ghana's Ministry of Health (MOH) and international organizations advocated for HTA
➡️Training activities and discussions led by MOH and supported by WHO increased awareness of HTA’s benefits
Looking ahead, Wilson and Görgens emphasize the need to integrate data on service quality, geography, and patient needs to ensure that health financing is not only efficient but also equitable and responsive.
Read more: bit.ly/3X98qrO
Read more: bit.ly/3X98qrO
November 3, 2025 at 12:57 PM
Looking ahead, Wilson and Görgens emphasize the need to integrate data on service quality, geography, and patient needs to ensure that health financing is not only efficient but also equitable and responsive.
Read more: bit.ly/3X98qrO
Read more: bit.ly/3X98qrO
These models also help make budget decisions more transparent and evidence-based, giving policymakers a powerful tool to defend data-driven choices in politically sensitive environments👇
November 3, 2025 at 12:57 PM
These models also help make budget decisions more transparent and evidence-based, giving policymakers a powerful tool to defend data-driven choices in politically sensitive environments👇
For instance, modeling studies across 23 countries found that optimized allocations could reduce new HIV infections by 18% and HIV-related deaths by 29% by 2030👇
November 3, 2025 at 12:57 PM
For instance, modeling studies across 23 countries found that optimized allocations could reduce new HIV infections by 18% and HIV-related deaths by 29% by 2030👇
The COVID-19 pandemic made efficiency a necessity. As budgets shrink, health systems must find new ways to do more with less.
Mathematical optimization models help governments simulate different budget scenarios and identify how to distribute resources most effectively across health programs👇
Mathematical optimization models help governments simulate different budget scenarios and identify how to distribute resources most effectively across health programs👇
November 3, 2025 at 12:57 PM
The COVID-19 pandemic made efficiency a necessity. As budgets shrink, health systems must find new ways to do more with less.
Mathematical optimization models help governments simulate different budget scenarios and identify how to distribute resources most effectively across health programs👇
Mathematical optimization models help governments simulate different budget scenarios and identify how to distribute resources most effectively across health programs👇
Both phases of HBP in Colombia had their own pros and cons. They reflected the tension between seeing health as a fundamental human right, regardless of cost, and prioritizing HBP based on available funding. Read more: bit.ly/45aFyT8
October 30, 2025 at 7:52 AM
Both phases of HBP in Colombia had their own pros and cons. They reflected the tension between seeing health as a fundamental human right, regardless of cost, and prioritizing HBP based on available funding. Read more: bit.ly/45aFyT8
But financial mismatches have persisted until today. Health care expenditure has been unable to cover all patient scenarios, leading to implicit rationing of health services👇
October 30, 2025 at 7:52 AM
But financial mismatches have persisted until today. Health care expenditure has been unable to cover all patient scenarios, leading to implicit rationing of health services👇
Later, in 2017, the priority-setting process shifted to exclusions. This promoted medical autonomy, reduced patient costs and efforts for legal action, and improved clinical and financial risk management for insurers👇
October 30, 2025 at 7:52 AM
Later, in 2017, the priority-setting process shifted to exclusions. This promoted medical autonomy, reduced patient costs and efforts for legal action, and improved clinical and financial risk management for insurers👇
However, the institutional arrangements for priority-setting became clearer and more stable, and the processes and methodologies more robust👇
October 30, 2025 at 7:52 AM
However, the institutional arrangements for priority-setting became clearer and more stable, and the processes and methodologies more robust👇
Also, the health system's financial sustainability faced threats from increased "acción de tutela" cases, which judicialize the right to health. Nevertheless, priority-setting frameworks improved, with clearer institutional arrangements and more robust processes👇
October 30, 2025 at 7:52 AM
Also, the health system's financial sustainability faced threats from increased "acción de tutela" cases, which judicialize the right to health. Nevertheless, priority-setting frameworks improved, with clearer institutional arrangements and more robust processes👇
The explicit priority-setting process focused on inclusions was implemented between 1993 and 2017. During this time, various institutions were created and eliminated to determine the services and technologies included in the HBP👇
October 30, 2025 at 7:52 AM
The explicit priority-setting process focused on inclusions was implemented between 1993 and 2017. During this time, various institutions were created and eliminated to determine the services and technologies included in the HBP👇